NOV 28: The Indian Pharmacopoeia Commission (IPC), Ghaziabad, has taken a significant step toward strengthening medicine and medical device safety by signing three key Memoranda of Understanding (MoUs) in Nagaland. The agreements were formalised with the Nagaland Medical Council, the Nagaland State Drugs Control Administration (NSDCA), and the Nagaland State Pharmacy Council during a one-day training programme on Pharmacovigilance and Materiovigilance held in Kohima.
The collaboration aims to enhance public health by promoting the safe and rational use of medicines, improving adverse drug reaction (ADR) reporting, and supporting the adoption of Indian Pharmacopoeia Reference Substances and Impurity Standards in state drug-testing laboratories. The training programme brought together experts and senior officials from the Ministry of Health and Family Welfare, including Shri Hoveyda Abbas, AS&FA, and Shri Anoop Khinchi, Secretary, Health & Family Welfare, Nagaland.
A major milestone of this initiative is IPC’s MoU with the Nagaland Medical Council—the first such agreement with any State Medical Council in India—designed to strengthen pharmacovigilance and materiovigilance activities down to primary health centres. The MoU with NSDCA marks IPC’s second partnership with a state drug authority and the first in the North Eastern region. The pact with the State Pharmacy Council makes it the fourth such council in the country to join hands with IPC.
These MoUs are expected to boost stakeholder capacity, expand ADR and medical device monitoring centres, and increase the use of the National Formulary of India across Nagaland’s healthcare facilities. IPC will provide technical support, while state agencies will coordinate with hospitals, pharmacists, medical colleges, and industry to strengthen patient safety systems.
, Ghaziabad, has taken a significant step toward strengthening medicine and medical device safety by){kind=link}